ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,474.33
0.43%
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs Yen
157.405
0.00%
Brent Oil
82.275
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Cara Therapeutics Inc (CARA)

  7. Cara Therapeutics Inc (CARA) ニュース

CARA

Cara Therapeutics (CARA)

Cara Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CARA
日付受信時刻ニュースソース見出しコード企業名
2024/06/1306 : 12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CARACara Therapeutics Inc
2024/06/1305 : 01GlobeNewswire Inc.Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia ParestheticaNASDAQ:CARACara Therapeutics Inc
2024/06/0805 : 10Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CARACara Therapeutics Inc
2024/06/0805 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CARACara Therapeutics Inc
2024/06/0705 : 28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
2024/06/0705 : 26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
2024/06/0705 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
2024/06/0705 : 24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
2024/05/1405 : 17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CARACara Therapeutics Inc
2024/05/1405 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CARACara Therapeutics Inc
2024/05/1405 : 01GlobeNewswire Inc.Cara Therapeutics Reports First Quarter 2024 Financial ResultsNASDAQ:CARACara Therapeutics Inc
2024/05/0705 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
2024/05/0620 : 00GlobeNewswire Inc.Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024NASDAQ:CARACara Therapeutics Inc
2024/04/0220 : 00GlobeNewswire Inc.Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:CARACara Therapeutics Inc
2024/03/0721 : 00GlobeNewswire Inc.Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024NASDAQ:CARACara Therapeutics Inc
2024/03/0706 : 45Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CARACara Therapeutics Inc
2024/03/0506 : 24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
2024/03/0506 : 19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
2024/03/0506 : 13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
2024/03/0506 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CARACara Therapeutics Inc
2024/03/0506 : 01GlobeNewswire Inc.Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:CARACara Therapeutics Inc
2024/02/1408 : 50Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CARACara Therapeutics Inc
2024/02/1307 : 16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
2024/02/1307 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
2024/02/1307 : 13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
2024/02/1307 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
2024/02/1306 : 01GlobeNewswire Inc.Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024NASDAQ:CARACara Therapeutics Inc
2024/02/0606 : 34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
2024/02/0606 : 32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
2024/02/0606 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CARA

最近閲覧した銘柄

NYSE
BAC
Bank of America
NASDAQ
GOOGL
Alphabet
NASDAQ
TSLA
Tesla
NYSE
CVX
Chevron
NYSE
MCD
McDonalds
USOTC
ADDYY
Adidas (QX)
NYSE
DIS
Walt Disney
NASDAQ
NVDA
NVIDIA
CCOM
US500
US 500
CCOM
US30
US 30
AMEX
XLV
Health Care Select Sector
NYSE
JPM
JP Morgan Chase
USI
USTECH100
US Tech 100
AMEX
SPY
SPDR S&P 500
AMEX
XLE
Energy Select Sector SPDR
COIN
SOLUSD
Solana
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有